Target Identification Professors and Supervisors | ApplySharif

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۱-۱۵ از ۶٬۰۶۶ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Herman Barkemaمشاهده پروفایل

استاد

University of CalgaryCanada

Herman Barkema is a Professor in Epidemiology of Infectious Diseases at the Faculty of Veterinary Medicine, University of Calgary, with a joint appointment in the Department of Community Health Sciences, Cumming School of Medicine. His research focuses on preventing infectious diseases in cattle herds (e.g., mastitis, Johne’s disease) and antimicrobial resistance, integrating animal and public health perspectives under the One Health framework. He founded the Department of Production Animal Health and leads the AMR – One Health Consortium and CAN-AMR-Net. DVM, Veterinary Medicine, Utrecht University (1988) PhD, Veterinary Science, Utrecht University (1998) His work spans clinical veterinary epidemiology, antimicrobial resistance mechanisms, and zoonotic disease control. He has over 425 publications and collaborates globally, including as a Foreign Expert at China Agricultural University. Recent research trends highlight his focus on multi-omics approaches, ceRNA networks, and antimicrobial stewardship in dairy systems, with significant contributions to Johne’s disease diagnostics and mastitis prevention. Roger Morris ISVEE Award (2024) Plowright Prize (2022) Killam Annual Professorship (2019) Multiple Journal of Dairy Science Most Cited Awards (2011–2024) Fellow, Canadian Academy of Health Sciences (2014) Dr. Barkema supervises graduate students and postdoctoral fellows, emphasizing interdisciplinary mentorship. He co-developed the Veterinary DialogueTrainer for clinical communication training and participates in public engagement initiatives like Breakfast on the Farm. He leads the AMR – One Health Consortium and CAN-AMR-Net, integrating stakeholders across Canada and internationally. His affiliations include the Snyder Institute for Chronic Diseases and strategic initiatives on Infectious Diseases and One Health (2015–2025).

پروفایل رسمی دانشگاه

Jimeng Sunمشاهده پروفایل

استاد

University of Illinois Urbana-ChampaignUnited States

Dr. Jimeng Sun is a Health Innovation Professor at the Siebel School of Computing and Data Science and Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign. Co-founder of Keiji AI , he leads groundbreaking research at the intersection of artificial intelligence and healthcare, actively deploying clinical AI systems and developing frameworks like PyHealth and Therapeutics Data Commons . His research spans four major areas: Clinical AI Systems : Developing interpretable models (e.g., RETAIN) for patient similarity, temporal event prediction, medication recommendation, and clinical outcome forecasting Drug Discovery : Creating molecular optimization frameworks, drug-target interaction models, and AI-driven platforms Clinical Trials : Pioneering patient-trial matching, outcome prediction, and optimization frameworks using deep learning and graph neural networks Biosignal Analysis : Advancing sleep staging, seizure classification, and automated EEG/Cardiac monitoring systems With over 500 top-tier publications (including in Nature , NEJM AI , and leading AI conferences) and an h-index of 99, his work has been recognized with the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare award. He maintains active collaborations with institutions like Massachusetts General Hospital , Medidata Solutions , and OSF Healthcare . His recent publications reveal a strong focus on: Reinforcement learning applications in medical data analysis Large language model adaptation for clinical tasks Knowledge graph integration with AI systems Synthetic data generation for healthcare Multi-modal learning in clinical contexts Explainable AI for medical applications Dr. Sun's lab ( Sunlab ) emphasizes practical impact over theoretical work, actively collaborating with hospitals and healthtech companies. He welcomes contributions from clinicians, researchers, and industry partners through initiatives like his AI for Health webinar series .

پروفایل رسمی دانشگاه

Sriram Subramaniamمشاهده پروفایل

استاد

University of British ColumbiaCanada

Sriram Subramaniam is a Professor in the Department of Biochemistry and Molecular Biology at the University of British Columbia (UBC) and holds the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design. His research leverages cryo-electron microscopy (cryo-EM) to advance structural biology and drug design, focusing on protein dynamics and therapeutic target identification. Education: PhD in Physical Chemistry (1987) from Stanford University; MSc in Chemistry (1981) from Indian Institute of Technology, Kanpur. Subramaniam's interdisciplinary work combines cryo-EM with computational tools and molecular biology to study protein structures at atomic resolution. His lab has pioneered cryo-EM applications in precision medicine, including mapping small molecule drugs on patient-specific cancer mutants. Recent publications (2024-2022) highlight his contributions to understanding SARS-CoV-2 immune evasion, structural mechanisms of ATPases, and AI integration in structural biology. His research spans viral entry mechanisms, CRISPR systems, and neurodegenerative disease pathways. Scientific Awards: Gobind Khorana Canada Excellence Research Chair NIH Director’s Award for Scientific Excellence Fellow of the Biophysical Society Breakthrough Prize nomination Based at the Djavad Mowafaghian Center for Brain Health, Subramaniam leads the Program in Cryo-EM Guided Drug Design, contributing to over 177 peer-reviewed publications with a career h-index of 58 and citations exceeding 12,340.

پروفایل رسمی دانشگاه

Pierre De Leoمشاهده پروفایل

استادیار

University of Maryland, College ParkUnited States

Pierre De Leo is an Assistant Professor in the Department of Economics at the University of Maryland. His research focuses on international macroeconomics, finance, and monetary policy, particularly the role of expectations in identifying economic shocks, exchange rate dynamics, and optimal policy conduct. During Spring 2025, he will also be visiting the Federal Reserve Bank of Boston. Education: PhD and MA in Economics, Boston College BA and MA in Economics (highest honors), University of Milan - Bicocca Research Interests: De Leo explores topics such as exchange rate fluctuations, monetary policy design, and the impact of global investors on bond markets. His work bridges theoretical frameworks with empirical analysis to address policy-relevant questions in open economies, emphasizing the interplay between expectations and macroeconomic outcomes. Recent Articles: His publications analyze themes like the disconnect between short-term interest rates and policy, speculation in emerging markets, and the implications of imperfect exchange rate expectations. These studies highlight his focus on bridging theory and real-world policy challenges. Labs/Teams: No specific labs or teams are explicitly mentioned in the provided texts. However, his research aligns with broader initiatives in international macroeconomics and monetary policy at the University of Maryland.

پروفایل رسمی دانشگاه

Moe Z. Winمشاهده پروفایل

استاد

Massachusetts Institute of TechnologyUnited States

Moe Z. Win is the Robert R. Taylor Professor at the Massachusetts Institute of Technology (MIT), specializing in wireless communications, optical communications, and space communications systems. His research bridges theoretical and applied domains, including quantum sensing, network localization, and signal processing. B.S.E.E., Texas A&M (1987) M.S.E.E. & Ph.D., University of Southern California (1989, 1998) Recent work focuses on quantum-enhanced positioning, machine learning for localization, and next-generation (xG) non-terrestrial networks. He leads research at the Quantum neXus Laboratory (QX Lab), Wireless Information & Network Sciences Lab, and Laboratory for Information and Decision Systems. His career spans the Jet Propulsion Laboratory (1987-1995) and AT&T Research Laboratories (1998-2002). Key methodologies include soft information fusion, variational quantum sensing, and robust beam tracking for terahertz communications.

پروفایل رسمی دانشگاه

Andreas Vlachosمشاهده پروفایل

استاد

University of CambridgeUnited Kingdom

Andreas Vlachos is a Professor of Natural Language Processing and Machine Learning at the Department of Computer Science and Technology, University of Cambridge, and holds the Dinesh Dhamija Fellowship at Fitzwilliam College. His research spans dialogue modeling, automated fact-checking, imitation learning, semantic parsing, biomedical text mining, and trustworthiness in AI systems. PhD in Computer Science, University of Cambridge (supervised by Ted Briscoe and Zoubin Ghahramani) Lecturer at University of Sheffield Postdoctoral roles at UCL, University of Cambridge (NLIP group, Stephen Clark), and University of Wisconsin-Madison (Mark Craven) Current research focuses on evaluating and mitigating biases in language models, advancing fact-checking methodologies, and improving model robustness through interpolation, reinforcement learning, and causal reasoning. His work integrates natural logic, knowledge graphs, and multimodal evidence for verification tasks. Recent publications address uncertainty quantification, temporal planning benchmarks, and ethical framing of NLP artifacts. Grants from ERC, EPSRC, Facebook, Google, and the Alan Turing Institute fund his research team. Collaborations include Sebastian Riedel, Stephen Clark, and Mark Craven. Key projects explore disinformation detection, long-form generation, and confidence calibration in AI systems.

پروفایل رسمی دانشگاه

Henrik Sandbergمشاهده پروفایل

استاد

KTH Royal Institute of TechnologySweden

Henrik Sandberg is a Professor at the Division of Decision and Control Systems , KTH Royal Institute of Technology , Stockholm, Sweden. He holds the title of Deputy Head of Division and is affiliated with the School of Electrical Engineering and Computer Science . Education: MSc in Engineering Physics (1999) PhD in Automatic Control (2004) from Lund University Postdoctoral position at Caltech (pre-2007) Research Interests: Focus on cyber-physical systems security , power systems , model reduction , and fundamental limitations of control systems . Key sub-areas include attack detection , networked control , privacy-preserving estimation , and resilient control architectures . Publications: Over 150 papers across IEEE Transactions and Automatica , covering topics like stealthy attacks , distributed control , LQG optimization , and thermodynamic costs in filtering . Recent work includes LWE-based encrypted control and Bayesian deception mechanisms . Scientific Awards: Best Student Paper Award Finalist at IEEE CASE 2014; Best Student-Paper Award at IEEE CDC 2004. Grants & Projects: Leads the DYNACON project (WASP Cybersec cluster) and collaborates on CERCES (critical infrastructure resilience). Serves as examiner for multiple advanced courses in cybersecurity and control systems. Contact: Email: hsan@kth.se Phone: +46 (0)8 790 7294 Room: A:607, Malvinas Väg 10, Stockholm

پروفایل رسمی دانشگاه

Paul Stuppleمشاهده پروفایل

استاد

Monash UniversityAustralia

Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.

پروفایل رسمی دانشگاه

Marcus Smithمشاهده پروفایل

دانشیار

Charles Sturt UniversityAustralia

Marcus Smith is an Associate Professor in Law at the Charles Sturt University , where he teaches LAW222 Technology Law and directs the Bachelor of Laws program. He holds advanced degrees from the Australian National University (PhD, LLM) and the University of Cambridge (MPhil). His research spans technology law and regulation , focusing on genomic data governance biometric identification AI ethics blockchain policy cybersecurity surveillance law He leads the Contemporary Threats to Australian Security research group and serves as Chief Investigator on an NHMRC-funded project (MRF2015531) addressing genomic dataset governance. His recent work analyzes algorithmic bias in facial recognition AI in healthcare blockchain's regulatory challenges post-pandemic cybercrime surveillance ethics data security frameworks He actively supervises PhD and honours students in technology law and contributes to law reform through submissions to international bodies like the UN Human Rights Council .

پروفایل رسمی دانشگاه

Weiping Tangمشاهده پروفایل

استاد

University of Wisconsin-MadisonUnited States

Weiping Tang is a Professor of Pharmaceutical Sciences and Chemistry at the University of Wisconsin-Madison, holding the Janis Apinis Professorship in the School of Pharmacy and the Vilas Distinguished Achievement Professorship. He also serves as Director of the Medicinal Chemistry Center at the School of Pharmacy and maintains a faculty appointment with the Department of Chemistry in the College of Letters and Science. Janis Apinis Professor of Pharmaceutical Sciences Vilas Distinguished Achievement Professor Director of Medicinal Chemistry Center Faculty Appointment with Department of Chemistry Dr. Tang received his B.S. in Chemistry from Peking University in 1997, M.S. in Chemistry from New York University in 1999, Ph.D. in Organic Chemistry from Stanford University in 2005, and completed a postdoctoral fellowship in Medicinal Chemistry, Chemical Biology and Drug Discovery at Harvard University in 2007. Dr. Tang's research program focuses on drug discovery for cancer, infectious diseases, and neurodegenerative disorders through three interconnected areas: Organic Synthesis (advancing glycoscience through novel carbohydrate synthesis technologies), Medicinal Chemistry (developing small molecules that selectively remove disease-associated proteins), and Chemical Biology (dissecting biological pathways using novel small molecule probes). His group operates as an interdisciplinary team where chemists and biologists collaborate closely on drug discovery projects, with particular emphasis on developing novel degraders for disease-causing proteins. Analysis of Dr. Tang's publication record reveals a significant shift toward targeted protein degradation technologies, particularly PROTACs and molecular glues, while maintaining strong foundations in carbohydrate chemistry. His most impactful recent work includes developing degraders for extracellular and membrane proteins (previously considered 'undruggable'), creating rapid synthesis platforms like Rapid-TAC and Rapid-Glue, and advancing understanding of ternary complex formation for novel PROTAC design. His research spans both chemical methodology development and therapeutic applications across multiple disease areas. Vilas Distinguished Achievement Professorship Janis Apinis Professorship Numerous high-impact publications in leading chemistry and pharmacology journals Editor's pick and hot paper designations for significant contributions Dr. Tang mentors a diverse team of graduate students, postdoctoral fellows, and staff scientists with expertise spanning synthetic chemistry, medicinal chemistry, carbohydrate chemistry, computational chemistry, biochemistry, and cell biology. His group has developed innovative platforms for the rapid synthesis of protein degraders and has made significant contributions to understanding the mechanisms of action for these novel therapeutics. Current research includes developing selective degraders for cancer targets like RIPK1, BRD4, and CARM1, as well as advancing delivery systems for clinical translation. The Tang Research Group maintains state-of-the-art facilities within the School of Pharmacy at UW-Madison, equipped for comprehensive chemical synthesis, compound characterization, and biological evaluation. The group actively collaborates with researchers across campus and with industry partners to advance discoveries toward clinical applications, with particular focus on cancer therapeutics and protein degradation technologies.

پروفایل رسمی دانشگاه

Yimin D. Zhangمشاهده پروفایل

دانشیار

Temple UniversityUnited States

Yimin D. Zhang is an Associate Professor in the Department of Electrical and Computer Engineering at Temple University's College of Engineering, where he leads the Advanced Signal Processing (ASP) Lab. His research spans statistical signal processing, array processing, radar, wireless communications, and convex optimization. Research Interests: Dr. Zhang's work focuses on cutting-edge signal processing techniques including compressive sensing, sparse arrays, time-frequency analysis, and robust beamforming. These are applied to radar systems, satellite navigation, assisted living, and wireless networks. His research addresses core challenges in target localization, direction-of-arrival estimation, and spectrum-efficient joint radar-communication systems. The recent publications highlight a strong trend in exploiting sparsity, virtual arrays, and deep learning to enhance resolution and robustness in radar and communication systems. Themes include multi-frequency processing, low-rank matrix recovery, and optimized OFDM waveforms for dual-function systems. Scientific Awards: 2016 IET Radar, Sonar and Navigation Premium Award 2017 IEEE Aerospace and Electronic Systems Society Harry Rowe Mimno Award 2018 IEEE Signal Processing Society Young Author Best Paper Award (coauthor) Advising and Grants: Dr. Zhang has served as Principal or Co-Principal Investigator on over $6 million in research funding from the NSF, AFRL, ONR, and DARPA. While student advisees are not listed, his leadership of the ASP Lab suggests active mentorship of graduate researchers. He contributes extensively to the academic community as an associate editor for IEEE Transactions on Signal Processing and editor for Signal Processing journal, and serves on key IEEE technical committees. Labs and Teams: He directs the Advanced Signal Processing (ASP) Lab at Temple University, which focuses on developing novel algorithms for real-world applications in radar, communications, and navigation. Previously, he led the Wireless Communications and Positioning Lab and the RFID Lab at Villanova University.

پروفایل رسمی دانشگاه

John P. O'Dohertyمشاهده پروفایل

استاد

California Institute of Technology (Caltech)United States

John P. O'Doherty serves as the Fletcher Jones Professor of Decision Neuroscience within Caltech's Division of Humanities and Social Sciences, holding continuous faculty appointments since 2004 (Assistant Professor 2004-07, Associate Professor 2007-09, Professor 2009-present, Fletcher Jones Professor 2021-present). He previously directed the Caltech Brain Imaging Center (2013-17) and maintains affiliations with the T&C Chen Center for Social and Decision Neuroscience. His educational background includes a B.A. from University of Dublin, Trinity College (1996) and D.Phil. from University of Oxford (2000). His research focuses on computational and neural mechanisms of reward-based learning and decision-making , employing fMRI, intracranial recordings, and mathematical modeling to investigate how the brain solves complex decision problems through evolutionarily conserved algorithms. Key areas include Reinforcement learning systems (model-based/model-free arbitration) Observational and social learning mechanisms Neural representation of value, risk, and uncertainty Computational phenotyping of mental disorders Temporal dynamics of goal persistence Analysis of his 2023-2025 publications reveals dominant trends in computational psychiatry (problem gambling, autism traits), hierarchical decision-making, and neuroeconomic modeling of social behavior. His work consistently integrates cross-species computational frameworks with human neuroimaging to identify transdiagnostic mechanisms. While specific awards beyond his endowed professorship aren't detailed, his leadership as Brain Imaging Center Director and prolific high-impact publications demonstrate significant recognition. Current advising includes graduate researcher Sneha Aenugu on goal-persistence projects, with administrative support from Mary A. Martin (mmartin@caltech.edu). His active research program continues to pioneer computational approaches to understanding decision pathologies.

پروفایل رسمی دانشگاه

Yogambha Ramaswamyمشاهده پروفایل

مدرس ارشد

University of SydneyAustralia

Dr. Yogambha Ramaswamy is a Senior Lecturer in the School of Biomedical Engineering at The University of Sydney and a member of the Sydney Nano Institute. She holds a Master’s in Biotechnology from the University of Queensland and a PhD in Biomedical Engineering from the University of Sydney (2009). Her postdoctoral career began as a Vice-Chancellor’s Postdoctoral Research Fellow at the University of New South Wales, followed by a Peter Doherty Early Career Fellowship in 2013 before joining the University of Sydney in 2015. Dr. Ramaswamy’s research focuses on biomaterials, tissue engineering, and mechanobiology, with a particular emphasis on developing calcium silicate-based ceramics and biopolymers for orthopedic and regenerative applications. Her recent work explores the role of physical cues in modulating stem and cancer cell behavior. She teaches courses such as AMME1961 (Introduction to Biomedical Engineering B) and AMME5962 (Introduction to Mechanobiology). Her research has been supported by grants including the NHMRC Early Career Fellowship and collaborations with institutions like the CSIR-Indian Institute of Chemical Technology and the University of Otago. Her publications span biomaterials, nanotechnology, and mechanobiology, with recent work addressing atherosclerosis, hydrogel design, and nanomedicine. She currently supervises PhD students Frank (biomaterials) and Alexander (atherosclerosis research).

پروفایل رسمی دانشگاه

Kelly Arnoldمشاهده پروفایل

دانشیار

University of Michigan-Ann ArborUnited States

Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.

پروفایل رسمی دانشگاه

Michele Klingbeilمشاهده پروفایل

استاد

University of Massachusetts AmherstUnited States

Michele Klingbeil is a Professor in the Department of Microbiology at the University of Massachusetts Amherst, where she leads the Klingbeil DNA Replication Laboratory. She received her PhD in Cell and Molecular Biology from the University of Toledo in 1996 and previously worked at Johns Hopkins School of Medicine before moving to UMass in July 2007. Her educational background includes: PhD in Cell and Molecular Biology, University of Toledo, 1996 Dr. Klingbeil's research focuses on the unique biology of trypanosomatid parasites, particularly Trypanosoma brucei , the causative agent of African sleeping sickness. Her laboratory investigates two main areas: (1) replication of the unusual mitochondrial DNA network called kinetoplast DNA (kDNA), and (2) nuclear DNA replication initiation. Her work on kDNA is particularly significant as this structure is essential for parasite survival but has no counterpart in mammalian hosts, making it an attractive drug target. She employs a combination of reverse genetics (RNAi), cell biology, and biochemistry to understand the replication and repair mechanisms of kDNA, with a special focus on a family of four DNA polymerases related to bacterial Pol I. Dr. Klingbeil's recent publications reveal her laboratory's deep investigation into mitochondrial DNA polymerases in trypanosomatids, with discoveries showing multiple polymerases having specialized functions in kDNA replication and repair. Her research has established that several of these polymerases are essential for parasite viability, opening new avenues for drug development. She has also made significant contributions to understanding the simplified Origin Recognition Complex in trypanosomatids compared to other eukaryotes. Dr. Klingbeil has received the Thomas G. Lessie Distinguished Lectureship Award for her impact on teaching at the graduate level. Her research is funded by the National Institutes of Health, U.S. Department of Agriculture, the Joeph P. Healey Endowment, and the University of Massachusetts Amherst. She has mentored numerous graduate and undergraduate students, including current PhD candidates Dave Bruhn, Jeniffer Concepción, and Juemin Luo, as well as visiting scholar Eva Vidal Rico. Her former students have gone on to positions at institutions including Dana Farber/Broad Institute, Regis College, and Flagship Ventures. The laboratory regularly participates in scientific conferences including the Molecular Parasitology Meeting at Woods Hole and the Kinetoplastid Molecular Cell Biology conference. Dr. Klingbeil teaches several courses including Parasitology (MICRO 590S), Parasitology Lab (MICRO 590L), Molecular Mechanisms of Pathogenesis (MICRO 797P), Advanced Cell Biology (MCB 641), and Writing in Microbiology (MICRO 360). Her laboratory organizes regular social events including pumpkin carving parties and outings to Six Flags New England and Mt. Sugarloaf.

پروفایل رسمی دانشگاه

فقط ۷۵۰ نتیجه اول نمایش داده می‌شود. برای رسیدن به نتایج دقیق‌تر، جست‌وجو را با فیلترها محدودتر کنید.